Itopride hydrochloride
SIGMA/SML0033 - ≥98% (HPLC)
Synonym: N-
CAS Number: 122892-31-3
Empirical Formula (Hill Notation): C20H26N2O4 ·HCl
Molecular Weight: 394.89
MDL Number: MFCD00881710
Linear Formula: C20H26N2O4 ·HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to tan |
| form | powder |
| InChI | 1S/C20H26N2O4.ClH/c1-22(2 |
| InChI key | ZTOUXLLIPWWHSR-UHFFFAOYSA |
| originator | Abbott |
| Quality Level | 100 ![]() |
| SMILES string | Cl.COc1ccc(cc1OC)C(=O)NCc |
| solubility | H2O: ≥48 mg/mL |
| storage condition | desiccated |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | Antagonist of dopamine D2-receptor with anticholinesterase activity. |
| Biochem/physiol Actions: | Itopride hydrochloride enhances the gastrointestinal motility by blocking the activity of dopamine on the D2 receptors, on the post-synaptic cholinergic nerves and by inducing the liberation of acetylcholine in the myenteric plexus. It also inhibits the hydrolysis of the released acetylcholine with the help of acetylcholinesterase. |
| Biochem/physiol Actions: | Itopride is an acetylcholinesterase (AChE) inhibitor and D2 dopamine receptor antagonist. Itopride is used as a gastroprokinetic agent. |
| Features and Benefits: | This compound was developed by Abbott . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| General description: | Itopride hydrochloride is a new prokinetic drug. |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS09 |
| Signal word | Warning |
| Hazard statements | H410 |
| Precautionary statements | P273 - P501 |
| Hazard Codes | N |
| Risk Statements | 50 |
| Safety Statements | 61 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


